Conex (LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION)
Welcome to the PulseAid listing for the Conex drug offered from LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
NON-PROPRIETARY NAME: | Dexbrompheniramine Maleate, Pseudoephedrine HCl |
SUBSTANCE NAME: | DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2007-11-01 |
END MARKETING DATE: | 0000-00-00 |
Conex HUMAN OTC DRUG Details:
Item Description | Conex from LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
LABELER NAME: | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2; 60(mg/1; mg/1) |
START MARKETING DATE: | 2007-11-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54859-702_4ea67627-d9ba-4dc7-9daf-fd8ef0cb9abe |
PRODUCT NDC: | 54859-702 |
APPLICATION NUMBER: | part341 |
Other DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: